SEC Form 4 · accession 0000899243-17-008971
AVEO PHARMACEUTICALS INC · AVEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael P Bailey
Officer — President & CEO · Director
Period of report
Mar 28, 2017
Accepted (ET)
Mar 30, 2017 · 9:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 28, 2017 | J | 100,000 | $0.50 | A | 168,848 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reports the purchase of shares in the underwritten public offering of common stock of AVEO Pharmaceuticals, Inc.